(Press-News.org) New Orleans, LA – The American Psychiatric Association (APA) Foundation has selected Rahn Baily, MD, DLFAPA, ACP, Professor and Chair of Psychiatry at LSU Health New Orleans School of Medicine, as the recipient of the 2024 Solomon Carter Fuller Award.
According to the APA Foundation, “The Solomon Carter Fuller Award—established in 1969 and named for Dr. Solomon Carter Fuller, recognized as the first Black psychiatrist in America—honors a Black citizen who has pioneered in an area that has significantly improved the quality of life for Black people.”
“We strongly feel that your demonstrated contributions and your exceptional achievements in the field of psychiatry make you an outstanding recipient of this award,” wrote Saul Levin, MD, Chair, Board of Directors, APA Foundation, and Rawle Andrews, Jr., Esq., APA Executive Director.
Dr. Bailey is also Assistant Dean of Community Engagement at LSU Health New Orleans School of Medicine. Before joining the LSU Health New Orleans faculty, he was Chairman of Psychiatry at Meharry Medical College, Wake Forest Medical School, and the National Medical Association.
Dr. Bailey’s early research focused on Psychotic Disorders/SPMI, grew to include Depressive Illness/Bipolar Mood D/O, and expanded to forensic topics, Competency, Confidentiality, and Risk Management. Currently, his focus is Health Disparities, Healthcare Reform, and Violence.
He has 86 peer-reviewed publications in more than 20 refereed journals and published three books -- Health Disparities, 2013; Gun Violence, 2018; and Intimate Partner Violence, 2020.
Dr. Bailey is an advocate for change. He served as the Chairman of the Board of Trustees of the National Medical Association/Cobb Research Foundation. He chaired the National Alumni Council Board of Trustees of the National Medical Fellowships and completed a six-year term on the Rutgers University Board of Trustees in 2020.
He served as the 113th President of the National Medical Association. In 2006, he was selected by his peers as the NMA Physician of the Year in Houston during the Hurricane Katrina crisis. He was selected Outstanding Faculty Member at the University of Texas Houston and American Medical Association Co-Chairman of the Commission to End Health Disparities, 2012-13. In 2022, Dr. Bailey received the National Medical Association Ernest Y. Williams, M.D. Clinical Scholars of Distinction Award.
His work has been seminal in assisting communities in caring for patients’ health, developing strategies to improve their health paradigms, and working to enhance the lives of young professionals.
“Dr. Bailey is an outstanding member of our leadership team,” notes Dr. Richard DiCarlo, Interim Dean of LSU Health New Orleans School of Medicine. “This honor recognizes his expertise in addressing some of society’s most pressing needs.”
The award will be presented at the APA Annual Meeting in New York next May.
_____________________________________________________________________________________
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's flagship health sciences university, LSU Health New Orleans includes a School of Medicine with campuses in Baton Rouge and Lafayette, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSU Health New Orleans faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSU Health New Orleans research enterprise generates jobs and enormous economic impact. LSU Health New Orleans faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu, http://www.twitter.com/LSUHealthNO, or http://www.facebook.com/LSUHSC.
# # #
END
LSU Health’s Bailey to receive prestigious national award
2023-11-17
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Significant "post-COVID" resurgence in invasive meningococcal disease
2023-11-17
A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic. Recently reported cases have mainly been caused by meningococcal serogroups that were less frequent before the pandemic, and there has been a particular uptick in cases among people aged 16 to 24. The results, published in the Journal of Infection and Public Health on October 12, ...
Scientists produce human norepinephrine neurons from stem cells, with significant implications for researching diseases like Alzheimer’s and Parkinson’s
2023-11-17
Researchers at the University of Wisconsin–Madison have identified a protein key to the development of a type of brain cell believed to play a role in disorders like Alzheimer’s and Parkinson’s diseases and used the discovery to grow the neurons from stem cells for the first time.
The stem-cell-derived norepinephrine neurons of the type found in a part of the human brain called the locus coeruleus may enable research into many psychiatric and neurodegenerative diseases and provide a tool for developing ...
Cheap medicines prevented migraine as well as expensive ones
2023-11-17
Migraine is more than just a headache. Often the pain is accompanied by nausea, vomiting, light sensitivity, and sound sensitivity. Chronic migraine can be disabling and may prevent many, especially women, from contributing to working life.
Still, it often takes a long time for migraine patients to find a treatment that works well for them. Researchers at the Norwegian Center for Headache Research (NorHead) have used data from the Norwegian Prescription Register to look at which medicines best prevent migraine in people in Norway:
“There has now been done a lot of research on this subject ...
Study reveals surprising link between malnutrition and rising antibiotic resistance
2023-11-17
University of B.C. researchers have uncovered startling connections between micronutrient deficiencies and the composition of gut microbiomes in early life that could help explain why resistance to antibiotics has been rising across the globe.
The team investigated how deficiencies in crucial micronutrients such as vitamin A, B12, folate, iron, and zinc affected the community of bacteria, viruses, fungi and other microbes that live in the digestive system.
They discovered that these deficiencies led to significant shifts in the gut ...
New study reveals the genetics of human head shape
2023-11-17
Researchers at the University of Pittsburgh and KU Leuven have discovered a suite of genes that influence head shape in humans. These findings, published this week in Nature Communications, help explain the diversity of human head shapes and may also offer important clues about the genetic basis of conditions that affect the skull, such as craniosynostosis.
By analyzing measurements of the cranial vault — the part of the skull that forms the rounded top of the head and protects the brain — the team identified 30 regions of the genome associated with different aspects of head shape, 29 of which have not been reported previously.
“Anthropologists ...
Miniature device offers peace of mind for diabetics
2023-11-17
The first glucose self-monitoring system created in 1970 weighed three pounds, was initially designed only for physicians’ offices and needed a large drop of blood for a reading. Over 50 years later, researchers at Texas A&M University are working to create a fully injectable continuous glucose monitor (CGM) so small it rivals a grain of rice and can be used with an external optical reader to measure sugar levels at any given time.
While CGMs have advanced over the last 25 years, current models can still be a nuisance to the user and the required upkeep may discourage use. To address this issue, two faculty members from the Department of Biomedical Engineering ...
Argonne receives funding to advance diversity in STEM
2023-11-17
The U.S. Department of Energy (DOE) has awarded DOE’s Argonne National Laboratory funding as part of the Reaching a New Energy Sciences Workforce (RENEW) initiative, aimed at fostering diversity in STEM and advancing innovative research opportunities.
DOE announced $70 million to support internships, training programs and mentorship opportunities at 65 different institutions, including 40 higher-learning institutions that serve minority populations. By supporting these partnerships, DOE aims to create a more diverse STEM talent pool capable of addressing ...
Research spotlight: prescribing of benzodiazepines in a homeless veteran population
2023-11-17
What Question Were You Investigating?
Despite elevated risk for substance use disorder and overdose death in the homeless population, benzodiazepine prescribing for this population has not been examined.
Our team therefore set out to answer the questions:
What is the rate of benzodiazepine prescribing to homeless vs. non-homeless veterans with mental illness in the VA system?
Are homeless veterans more likely to receive risky and potentially inappropriate prescriptions?
What Methods Did You Use?
We used logistic regression to compare likelihood of benzodiazepine prescribing and t tests to compare ...
First human clinical trial for pill-sized device that monitors breathing from the gut
2023-11-17
Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool, described November 17 in the journal Device, has the potential to provide accessible and convenient care for people at risk of opioid overdose.
“The ability to facilitate diagnosis and monitor many conditions without having to go into a hospital can provide patients with easier access to healthcare and support treatment,” says Giovanni Traverso, the first author of the paper, associate professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology and gastroenterologist at Brigham ...
Ingestible vital signs monitor shows promise in first-in-human trial
2023-11-17
What if, instead of going into a sleep lab or being connected to monitoring devices, a patient could have their risk of obstructive sleep apnea measured by swallowing a pill? A new collaborative study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, Massachusetts Institute of Technology, Celero Systems and West Virginia University, evaluated a wireless ingestible device that can accurately report vital signs like heart and respiratory rate. The team tested the device, known as the Vitals Monitoring Pill (VM Pill), in a pilot ...